Scandinavian ChemoTech AB (publ) announced that it has been granted two significant patent approvals by The Patent Office, Government of India. This implies that there won't be a requirement to engage in public tenders; rather, a simplified procurement process will be in place. The Patent Office, Government of India has approved two of the Company's patent applications.

The now granted patent is a protection of the proprietary TSE technology, specifically, the creation of dynamic pulses, as well as the specialised probe and treatment kits, the protection extends to 2038.